Radhika Raheja

Harnessing Costus species for sustainable nanoparticle synthesis and biological applications

Nazish Khan, Radhika Raheja

in (code pays fourni par la source)

Evaluation of the Protective Effects of Moringa oleifera, Zingiber officinale, and Allium sativum in a Rat Model of Chronic Kidney Disease (CKD)

Manjiri P. Jalgaonkar, Rajeshwari Bale, Alok D Singh, Gaurav Doshi et autres

Background: Oxidative stress plays a key role in the development and progression of chronic kidney disease (CKD). In this study, it has been hypothesized that the extract of Moringa oleifera leaves, Zingiber officinale rhizomes, and Allium sativum cloves together might exert a …

in, us (code pays fourni par la source)

Costus speciosus extract: a natural immunomodulator for treatment of psoriasis in BALB/c mice by NF-κB pathway

Aditi Vyas, Muqtada Shaikh, Radhika Raheja, Gaurav Doshi

Psoriasis is a chronic inflammatory skin condition. Ayurveda, Traditional Chinese therapy, and Unani offer a potential approach to treating psoriasis. This study explores the immunomodulatory effects of Costus speciosus petroleum ether extract (CSPE) on psoriasis-like symptoms in Balb/c mice. GC-MS analysis was …

in (code pays fourni par la source)

Green High-Performance Thin-Layer Chromatography: A Step Towards Eco-Friendly Analysis

N Toushif Khan, Radhika Raheja

in (code pays fourni par la source)

Unilateral Blaschkoid Linear Atrophoderma of Moulin

Prasanna Kumar Jha, Satyendra Kumar Singh, Radhika Raheja, Hem Shankar Yadav

Linear atrophoderma of Moulin was first described by Moulin in 1992, as an acquired hyperpigmented atrophic band along Blaschko’s lines. We present a typical unilateral Linear Atrophoderma of Moulin in a young male along Blaschko’s line. This case is presented because of …

in, np (code pays fourni par la source)

753 AgenT-797 cell therapy can be combined with next-generation immune checkpoint inhibitors (ICI) and/or bi-specific engagers to improve anti-cancer response

Martyna C. Popis, Efrat Altman Sharoni, Shanmugarajan Krishnan, Deborah Wright et autres

Background Targeted cancer therapy aims to eradicate cancer cells while preserving healthy tissue, significantly improving the therapeutic index compared to conventional treatments. Antibodies are crucial in these targeted therapies due to their exceptional specificity for target antigens. Advancements in T-cell biology have …

us (code pays fourni par la source)

Atypical Scleromyxedema with Dramatic Response to Low Dose Prednisolone and Thalidomide

Satyendra Kumar Singh, Prasanna Kumar Jha, Radhika Raheja, Ankita Kumari et autres

Scleromyxedema is a rare condition which is clinically characterized by asymptomatic to itchy generalized papular and sclerodermoid eruption with histological findings which include mucin deposition and fibroblast proliferation. It can be associated with monoclonal gammopathy. Abnormalities in thyroid function must be ruled …

in, np (code pays fourni par la source)

Review of: "Exploring the Significance and Medicinal Potential of Rubus fraxinifolius: A Review of Ragimot Wildberry"

Radhika Raheja

in (code pays fourni par la source)

Review of: "Unravelling the Phytochemical and Pharmacognosy Contour of Traditional Medicinal Plant: Pterocarpus Marsupium Roxb"

Radhika Raheja

The review article collates the available data on the pharmacological spectrum of Pterocarpus Marsupium Roxb.However, there is a need to improve the language, which in certain places confuses the reader.After revision, the article

in (code pays fourni par la source)

Review of: "[Review Article] Nanocarriers for Protein and Peptide Drug Delivery"

Radhika Raheja

Potential competing interests: No potential competing interests to declare.The review, with the current contents does not impressively collate

in (code pays fourni par la source)

An Update on Potential Antidepressants Derived from Marine Natural Products

Priya P. Shejul, Radhika Raheja, Gaurav Doshi

INTRODUCTION: Depression is one of the most frequently occurring psychiatric disorders worldwide, affecting 121 million worldwide. World Health Organization (WHO) estimates that it is the leading cause of disability and the fourth leading contributor to the "global burden of diseases". OBJECTIVE: Investigating …

in (code pays fourni par la source)

Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple Sclerosis

Felipe von Glehn, Nathalie L.M.M. Pochet, Bibek R. Thapa, Radhika Raheja et autres

The purpose of this study was to examine whether myeloid dendritic cells (mDCs) from patients with multiple sclerosis (MS) and healthy controls (HCs) become similarly tolerogenic when exposed to IL-27 as this may represent a potential mechanism of autoimmune dysregulation. Our study …

us, br (code pays fourni par la source)